CClinicalTrials.gg
CompletedNCT01569607Updated Jan 16, 2018Results posted

Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation

An interventional study of Repetitive Transcranial Magnetic Stimulation (rTMS) and Sham stimulation in Stroke, sponsored by Cathrin Buetefisch. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-01-16.

Sponsored by Cathrin Buetefisch · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Stroke is a leading cause of morbidity in the United States but identification of treatment strategies to improve outcome is limited by the incomplete understanding of the mechanisms of recovery. Motor cortex (M1) reorganization plays a major-role in the recovery of motor deficits post-stroke; hence the importance for further development of rehabilitative strategies that utilize this potential for recovery.

In Specific Aim 1, investigators will determine if repeated exposure to training combined with Hebbian-type M1 stimulation enhances functional M1 reorganization in lesioned M1 of stroke patients.

In Specific Aim 2, investigators will determine if repeated exposure to training combined with Hebbian-type M1 stimulation enhances structural cortical reorganization in lesioned M1 of stroke patients and to explore whether these structural changes are related to the training induced functional cortical reorganization.

The overall goal of this project is to determine the effect of Hebbian- type stimulation on both, functional and structural brain reorganization, thereby obtaining indirect evidence for the neuronal substrate underlying training related improvement and maintenance of motor function in stroke patients. This knowledge may have a substantial positive impact on treatment for stroke patients that may significantly improve recovery and could move the field of neuro-rehabilitation forward.

Read the detailed description

Stroke is a leading cause of morbidity in the United States but identification of treatment strategies to improve outcome is limited by the incomplete understanding of the mechanisms of recovery. Motor cortex (M1) reorganization plays a major-role in the recovery of motor deficits post-stroke; hence the importance for further development of rehabilitative strategies that utilize this potential for recovery. Non-invasive cortical stimulation can enhance the beneficial effects of motor training on performance and functional plasticity of motor cortex. Among the different approaches used in these studies, Hebbian-type M1 stimulation is particularly intriguing, as it seems to be more effective when compared to random M1 stimulation. There is emerging evidence that motor training or cortical stimulation related improvement of function are associated with increases in the grey matter of targeted brain areas. While there is therefore some evidence supporting structural reorganization in human M1 in response to motor learning and cortical stimulation, the mechanisms underlying these changes and their relationship to functional plasticity are not known. A better understanding of the sequences of events is critical to development of optimal therapeutic interventions to improve recovery following stroke.

In Specific Aim 1, investigators will determine if repeated exposure to training combined with Hebbian-type M1 stimulation enhances functional M1 reorganization in lesioned M1 of stroke patients.

In Specific Aim 2, investigators will determine if repeated exposure to training combined with Hebbian-type M1 stimulation enhances structural cortical reorganization in lesioned M1 of stroke patients and to explore whether these structural changes are related to the training induced functional cortical reorganization.

The overall goal of this project is to determine the effect of Hebbian- type stimulation on both, functional and structural brain reorganization, thereby obtaining indirect evidence for the neuronal substrate underlying training related improvement and maintenance of motor function in stroke patients. This knowledge may have a substantial positive impact on treatment for stroke patients that may significantly improve recovery and could move the field of neuro-rehabilitation forward.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Neurophysiology
  • Transcranial Magnetic Stimulation (TMS)
  • Neurology
  • Stroke
  • Physical Medicine and Rehabilitation
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 48 is close to the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Cathrin Buetefisch is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Age 18-85
  • Single cerebral ischemic infarction > 6 month affecting the primary motor output system of the hand at a cortical (M1) level as defined by MRI of the brain
  • At the time of cerebral infarct a motor deficit of hand of MRC of \<4- of wrist and finger extension/flexion movement
  • Good recovery of hand function as defined by MRC of 4 or 4+ of wrist- and finger extension/flexion movements
  • Ability to perform wrist extension movements
  • No other neurological disorder
  • No intake of CNS active drugs
  • Ability to give informed consent
  • Ability to meet criteria of inclusion experiment
  • No major cognitive impairment
  • No contraindication to TMS or MRI
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Hebbian-type Stimulation

    Participants will be randomized to receive motor training with Hebbian-type stimulation.

    Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

  • Sham comparator
    Sham Stimulation

    Participants will be randomized to receive sham stimulation.

    Device: Sham stimulation

Interventions

  • DeviceRepetitive Transcranial Magnetic Stimulation (rTMS)

    Training sessions for 5 days in a row

  • DeviceSham stimulation

    Sham stimulation

06

What researchers measure

Primary outcomes

  1. Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve

    Motor evoked potential (MEP) amplitudes were measured prior to treatment (baseline), one week after the treatment (post-training 1), and 4 weeks after treatment (post-training 2).The MEP is elicited by transcranial magnetic stimulation (TMS) at increased intensity. Its amplitude is measured from peak to peak and expressed in millivolts (mV). Measured MEP amplitudes were plotted against the intensity to create a stimulus response curve (SRC). Long-lasting increases in MEP amplitude indicate increases in motor cortex excitability and are associated with motor learning.

    Time frame: Baseline, Post-Training 1 (1 Week), Post-Training 2 (4 Weeks)

Secondary outcomes

  1. Mean Time to Completion for Jebsen Hand Function Test (JTT)

    The JTT provides a standardized and objective evaluation of fine and gross motor hand function using simulated activities of daily living assessing the speed of performance. Total score is the sum of time taken for each sub-test, which were normalized to standard scores (also expressed in seconds).Total scores range from +1 to -1 where -1 indicates best function.

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  2. Mean Peak Acceleration of Wrist Extension Movements

    Mean peak acceleration was measured at baseline, one week after the treatment (post-training 1), and four weeks after the treatment (post-training 2). Increases in the mean peak acceleration of the trained wrist extension movements indicate motor learning. Acceleration was measured in g; a symbol for the average acceleration produced by gravity at the Earth's surface.

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  3. Mean Reaction Time of Wrist Extension Movements

    Subjects will be asked to perform 7 auditory-cued ballistic wrist extensions before and after motor training. Electromyographic (EMG) activity recorded during the ballistic wrist extensions will be used to measure reaction time. Reaction time is the length of time between the auditory cue and the onset of the movement-related EMG burst of the extensor carpi ulnaris muscle. A longer time indicated longer time to reaction.

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  4. Mean Motor Activity Log (MAL) Score: Amount Subtest

    Individuals are asked to rate amount of movement during 30 daily functional tasks. Items are scored on a 0 to 6-point ordinal scale as follows: 0 = The weaker arm was not used at all for that activity (never) 1 = Occasionally used weaker arm, but only very rarely (very rarely) 2= Sometimes used weaker arm, but did the activity most of the time with stronger arm (rarely) 3 = Used weaker arm about half as much as before the stroke (half pre-stroke) 4 = Used weaker arm almost as much as before the stroke (3/4 pre-stroke) 5 = The ability to use the weaker arm for that activity was as good as before the stroke (normal) Total scores range from 0 to 140; 0 indicating the least movement 140 indicating the most movement. The scores were converted into percentage scores where higher percent score indicate more movement and lower percent score less movement.

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  5. Mean Motor Activity Log (MAL): How Well Subtest

    Individuals are asked to rate quality of movement during 30 daily functional tasks. Items are scored on a 6-point ordinal scale as follows: 0=The weaker arm was not used at all for that activity (never); 1=The weaker arm was moved during that activity, but was not helpful (very poor); 2=The weaker arm was of some use during the activity, but needed help from the stronger arm or moved very slowly or with difficulty (poor); 3=The weaker arm was used for the purpose indicated, but movements were slow or were made with only some effort (fair); 4=The movements made by the weaker arm were almost normal, but were not quite as fast or accurate as normal (almost normal); 5=The ability to use the weaker arm for that activity was as good as before the stroke (normal) Total scores range from 0 to 140; 0 indicating the least movement and 140 indicating the most movement.

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  6. Mean Wolf Motor Function Test (WMFT) Total Time

    The Wolf Motor Function Test (WMFT) is a quantitative index of upper extremity motor ability examinable through the use of timed and functional tasks. There are 15 timed tasks included with a time cap of 120 seconds. The max amount of time to completion is 1800 seconds if all tasks are failed. The time in seconds were summed across all the tasks to obtain the total duration. Values in the table represent the time taken in seconds to successfully complete all 15 tasks).

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  7. Mean Wolf Motor Function Test Functional Ability (WMFT-FS) Scale Score

    The WMFT is a 17 item scale that quantifies upper extremity (UE) motor ability through timed and functional tasks. The items are rated on a 6-point scale.Total scores can range from 17 to 102. Lower scores indicate debilitating mobility (such as no or limited functionality), while higher score indicate greater mobility (such as slow movement and normal movement).

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  8. Mean Wolf Motor Function Test (WMFT) Grip Strength

    Participants attempt to grip the dynamometer with greatest grip strength possible. The test should be conducted 3 times with a 1-minute rest between trials. The mean of grip strength exerted (kg) on 3 trials is then calculated.

    Time frame: Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

07

Results

Posted Jan 16, 2018

Participant flow

Participants were recruited between March 2012 and August 2016.

Participant flow — Overall Study
MilestoneHebbian-type StimulationSham Stimulation
Started1111
Completed1010
Not completed11

Outcome measures

PrimaryPrimary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve

Motor evoked potential (MEP) amplitudes were measured prior to treatment (baseline), one week after the treatment (post-training 1), and 4 weeks after treatment (post-training 2).The MEP is elicited by transcranial magnetic stimulation (TMS) at increased intensity. Its amplitude is measured from peak to peak and expressed in millivolts (mV). Measured MEP amplitudes were plotted against the intensity to create a stimulus response curve (SRC). Long-lasting increases in MEP amplitude indicate increases in motor cortex excitability and are associated with motor learning.

Time frame:
Baseline, Post-Training 1 (1 Week), Post-Training 2 (4 Weeks)
Reported as:
Mean · millivolts
Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve
millivoltsHebbian-type StimulationSham Stimulation
Baseline4.68 ± 5.659.09 ± 11.28
Post-Training Week 15.01 ± 5.968.04 ± 9.28
Post-Training Week 42.66 ± 2.557.66 ± 10.67
SecondaryMean Time to Completion for Jebsen Hand Function Test (JTT)

The JTT provides a standardized and objective evaluation of fine and gross motor hand function using simulated activities of daily living assessing the speed of performance. Total score is the sum of time taken for each sub-test, which were normalized to standard scores (also expressed in seconds).Total scores range from +1 to -1 where -1 indicates best function.

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · units on a scale
Mean Time to Completion for Jebsen Hand Function Test (JTT)
units on a scaleHebbian-type StimulationSham Stimulation
Baseline.38 ± .23.49 ± .21
Post-Training Week 1.34 ± .26.45 ± .20
Post-Training Week 4.31 ± .26.44 ± .21
SecondaryMean Peak Acceleration of Wrist Extension Movements

Mean peak acceleration was measured at baseline, one week after the treatment (post-training 1), and four weeks after the treatment (post-training 2). Increases in the mean peak acceleration of the trained wrist extension movements indicate motor learning. Acceleration was measured in g; a symbol for the average acceleration produced by gravity at the Earth's surface.

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · g
Mean Peak Acceleration of Wrist Extension Movements
gHebbian-type StimulationSham Stimulation
Baseline.61 ± .48.60 ± .32
Post-Training Week 1.72 ± .32.79 ± .49
Post-Training Week 4.71 ± .32.81 ± .47
SecondaryMean Reaction Time of Wrist Extension Movements

Subjects will be asked to perform 7 auditory-cued ballistic wrist extensions before and after motor training. Electromyographic (EMG) activity recorded during the ballistic wrist extensions will be used to measure reaction time. Reaction time is the length of time between the auditory cue and the onset of the movement-related EMG burst of the extensor carpi ulnaris muscle. A longer time indicated longer time to reaction.

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · milliseconds
Mean Reaction Time of Wrist Extension Movements
millisecondsHebbian-type StimulationSham Stimulation
Baseline238.1 ± 77.40257.14 ± 88.13
Post-Training Week 1238.43 ± 36.38224.59 ± 63.69
Post-Training Week 4219.63 ± 67.55225.35 ± 75.05
SecondaryMean Motor Activity Log (MAL) Score: Amount Subtest

Individuals are asked to rate amount of movement during 30 daily functional tasks. Items are scored on a 0 to 6-point ordinal scale as follows: 0 = The weaker arm was not used at all for that activity (never) 1 = Occasionally used weaker arm, but only very rarely (very rarely) 2= Sometimes used weaker arm, but did the activity most of the time with stronger arm (rarely) 3 = Used weaker arm about half as much as before the stroke (half pre-stroke) 4 = Used weaker arm almost as much as before the stroke (3/4 pre-stroke) 5 = The ability to use the weaker arm for that activity was as good as before the stroke (normal) Total scores range from 0 to 140; 0 indicating the least movement 140 indicating the most movement. The scores were converted into percentage scores where higher percent score indicate more movement and lower percent score less movement.

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · units on a scale
Mean Motor Activity Log (MAL) Score: Amount Subtest
units on a scaleHebbian-type StimulationSham Stimulation
Baseline78.67 ± 23.1678.00 ± 24.76
Post-Training Week 181.00 ± 23.6379.00 ± 25.39
Post-Training Week 484.67 ± 23.2177.33 ± 25.42
SecondaryMean Motor Activity Log (MAL): How Well Subtest

Individuals are asked to rate quality of movement during 30 daily functional tasks. Items are scored on a 6-point ordinal scale as follows: 0=The weaker arm was not used at all for that activity (never); 1=The weaker arm was moved during that activity, but was not helpful (very poor); 2=The weaker arm was of some use during the activity, but needed help from the stronger arm or moved very slowly or with difficulty (poor); 3=The weaker arm was used for the purpose indicated, but movements were slow or were made with only some effort (fair); 4=The movements made by the weaker arm were almost normal, but were not quite as fast or accurate as normal (almost normal); 5=The ability to use the weaker arm for that activity was as good as before the stroke (normal) Total scores range from 0 to 140; 0 indicating the least movement and 140 indicating the most movement.

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · units on a scale
Mean Motor Activity Log (MAL): How Well Subtest
units on a scaleHebbian-type StimulationSham Stimulation
Baseline3.41 ± .963.17 ± 1.18
Post-Training Week 13.64 ± 1.043.48 ± 1.23
Post-Training Week 43.92 ± .963.33 ± 1.21
SecondaryMean Wolf Motor Function Test (WMFT) Total Time

The Wolf Motor Function Test (WMFT) is a quantitative index of upper extremity motor ability examinable through the use of timed and functional tasks. There are 15 timed tasks included with a time cap of 120 seconds. The max amount of time to completion is 1800 seconds if all tasks are failed. The time in seconds were summed across all the tasks to obtain the total duration. Values in the table represent the time taken in seconds to successfully complete all 15 tasks).

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · seconds
Mean Wolf Motor Function Test (WMFT) Total Time
secondsHebbian-type StimulationSham Stimulation
Baseline120.84 ± 230.77130.04 ± 153.06
Post-Training Week 191.31 ± 169.8399.02 ± 131.79
Post-Training Week 499.81 ± 206.7791.42 ± 118.77
SecondaryMean Wolf Motor Function Test Functional Ability (WMFT-FS) Scale Score

The WMFT is a 17 item scale that quantifies upper extremity (UE) motor ability through timed and functional tasks. The items are rated on a 6-point scale.Total scores can range from 17 to 102. Lower scores indicate debilitating mobility (such as no or limited functionality), while higher score indicate greater mobility (such as slow movement and normal movement).

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · units on a scale
Mean Wolf Motor Function Test Functional Ability (WMFT-FS) Scale Score
units on a scaleHebbian-type StimulationSham Stimulation
Baseline4.07 ± .574.08 ± .72
Post-Training Week 14.31 ± .554.29 ± .62
Post-Training Week 44.34 ± .544.13 ± .54
SecondaryMean Wolf Motor Function Test (WMFT) Grip Strength

Participants attempt to grip the dynamometer with greatest grip strength possible. The test should be conducted 3 times with a 1-minute rest between trials. The mean of grip strength exerted (kg) on 3 trials is then calculated.

Time frame:
Baseline, Post-Training (1 Week), Post-Training (4 Weeks)
Reported as:
Mean · kilograms
Mean Wolf Motor Function Test (WMFT) Grip Strength
kilogramsHebbian-type StimulationSham Stimulation
Baseline20.80 ± 13.9822.30 ± 12.72
Post-Training Week 122.30 ± 19.1020.30 ± 9.04
Post-Training Week 420.90 ± 13.7320.00 ± 11.57

Adverse events

Collected over Adverse events were collected from baseline measurements through week 5.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Hebbian-type Stimulation—0/11 (0%)0/11 (0%)
Sham Stimulation—0/11 (0%)0/11 (0%)

Baseline characteristics

Participants that were randomized to a study arm and received an intervention.

Age, Categorical
Age, Categorical(Participants)Hebbian-type StimulationSham StimulationTotal
<=18 years000
Between 18 and 65 years7613
>=65 years459
Sex: Female, Male
Sex: Female, Male(Participants)Hebbian-type StimulationSham StimulationTotal
Female6511
Male5611
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Hebbian-type StimulationSham StimulationTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(Participants)Hebbian-type StimulationSham StimulationTotal
United States111122
08

Study locations

1 site
  • Emory University School of Medicine
    Atlanta, Georgia 30322, United States
09

References and documents

Publications

  • Revill KP, Haut MW, Belagaje SR, Nahab F, Drake D, Buetefisch CM. Hebbian-Type Primary Motor Cortex Stimulation: A Potential Treatment of Impaired Hand Function in Chronic Stroke Patients. Neurorehabil Neural Repair. 2020 Feb;34(2):159-171. doi: 10.1177/1545968319899911. Epub 2020 Jan 24. PubMed 31976804 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01569607
Lead sponsor
Cathrin Buetefisch
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Cathrin Buetefisch (Dr. Cathrin Buetefisch, MD, PhD, Emory University) — Sponsor-investigator
First posted
Apr 3, 2012
Start date
Mar 8, 2012
Primary completion
Aug 26, 2016
Completion
Aug 26, 2016
Results posted
Jan 16, 2018
Last update
Jan 16, 2018

Study contacts

Cathrin Buetefisch, MD, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion